A Less Expensive, More Convenient Treatment Option for MS? A Less Expensive, More Convenient Treatment Option for MS?

Two phase 3 studies provide"delightful" new data for ublituximab, a novel investigational drug for multiple sclerosis, investigators report.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news